Trelleborg Breaks Ground on New Facility in Costa Rica & Other Supplier NewsTrelleborg Breaks Ground on New Facility in Costa Rica & Other Supplier News

Keeping you up to date with the latest supplier news.

Omar Ford

March 1, 2024

3 Slides

Already have an account?

Image courtesy of Trelleborg

Trelleborg Healthcare & Medical is breaking ground on a 107,600 square feet/10,000 square meter manufacturing facility in Costa Rica with construction scheduled to be completed in 2025. The facility will be in the Evolution Free Zone Industrial Park in the Alajuela Province in the town of Grecia.

The decision for the new site is driven by Trelleborg Healthcare & Medical’s strategic goal to help customers consolidate their value chains, reducing overall costs. As the company’s first facility in Central America, it will facilitate supply chain continuity through a global manufacturing and distribution base and support key customers in nearshoring production.

Capabilities offered at the facility will include liquid silicone rubber molding, dipping, thermoplastic production, and assembly to support key initiatives and growth plans of customers in critical healthcare and medical applications. It will also feature cleanroom production and be designed to meet stringent industry-specific standards for medical device manufacturing.

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like